Frontlight ResearchEarly access
Trial site
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Multiple myeloma2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Neuroendocrine tumours1 trial
- Ovarian cancer1 trial
- and 4 more
- Phase
- Phase 2/32 trials
- Phase 32 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Bristol-Myers Squibb2 trials
- Celgene1 trial
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial
- Loxo Oncology, Inc.1 trial
- Tanabe Pharma America, Inc.1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
- Neuroendocrine tumours1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Sarcoma1 recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026